• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CVT
Click for more information
3.85% 81.0¢

Comvita Limited

watchlist Created with Sketch. Add to my watchlist
Consumer Defensive Household & Personal Products

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CVT
Ann: AMENDED: Bank covenant waiver and trading update 		20/12/24 0 129
20/12/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  129 
CVT
Ann: Bank covenant waiver and trading update 		19/12/24 0 79
19/12/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  79 
CVT
Ann: Accounting irregularities impact prior periods 		09/12/24 0 123
TRENDING NEWS

Zero Commissions Doesn’t Mean Free Trades. IBKR has no hidden fees on US Stocks. What about your broker? Read more at ibkr.com.au/info

Find out more right-arrow Created with Sketch.
NEWS
16 Jan 2025
09/12/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  123 
CVT
Ann: Performance Share Rights - Capital Change Notice 		31/10/24 0 123
31/10/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  123 
CVT
Ann: Comvita advises results of resolutions at Annual Meeting 		30/10/24 0 111
30/10/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  111 
CVT
Ann: Comvita 2024 Annual Shareholders' Meeting 		30/10/24 0 132
30/10/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  132 
CVT
Ann: D&O Ongoing Disclosure Notice 		04/10/24 0 124
04/10/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  124 
CVT
Ann: Performance Share Rights - Capital Change Notices 		03/10/24 0 87
03/10/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  87 

See All Discussions arrow Created with Sketch.

Featured News

NEWS Gold Mountain Uncovers Significant Lithium Anomalies at Salinas South, Brazil
right-arrow Created with Sketch.
NEWS First Paediatric Patient Recruited for ACTION3 Phase 3 Clinical Trial
right-arrow Created with Sketch.
3DA The US will keep funding onshore manufacturing. Amaero's already winning
right-arrow Created with Sketch.
NEWS Syrah awarded ~US$165 Million Tax Credit for Vidalia expansion
right-arrow Created with Sketch.
AZ9 High grade massive sulphide intercepts confirmed at Oval
right-arrow Created with Sketch.
NEWS Sandover Fluorite assays show ultra high-grade results
right-arrow Created with Sketch.
(20min delay)
Last
81.0¢ 		Change
0.030(3.85%) 		Mkt cap ! n/a
Open High Low Value Volume
78.0¢ 81.0¢ 78.0¢ $2.666K 3.394K

Buyers (Bids)

No. Vol. Price($)
0 128 78.0¢
 

Sellers (Offers)

Price($) Vol. No.
81.0¢ 822 0
Last trade - 12.59pm 16/01/2025 (20 minute delay) ?
CVT (NZSX) Chart

Top Stories

HotCopper Highlights: Your most watched stocks for Week 2, 2025

Welcome back! It's 2025, and traders are looking for stockpicking opportunities. Here's what HotCopper users are watching.
Tabcorp up more than 5% after appointing 'one of the world's most sought-after wagering executives' Tabcorp Holdings Ltd has seen its share price rise after announcing the appointment of top wagering executive Michael Fitzsimons
Week 2 Wrap: Insignia denies Brookfield bid; Star teetering; 1.5C breached & Samsung’s AI TVs It's been a strange week, and it's the first of the year (sort of.) Exxon's suing Twiggy; Samsung's got AI TVs. Then there's climate change.
Southern Cross Gold Consolidated's January 'IPO' is all a bit confusing. Here's what happened Southern Cross Gold Consolidated will be ringing the bell on the ASX today at 3PM in Sydney, and while it is listed as a float, it’s a little more complicated than that @ today’s IPO is really arriving on a deferred settlement basis.In the simplest sense, this is a...
Dimerix signs up first patient for 'highly significant' paediatric clinical trial Dimerix Limited (ASX:DXB), a Melbourne-based biopharmaceutical company, has started recruitment for its first paediatric patient for the Phase 3 ACTION3 clinical trial in a major next step for the research.The trial will investigate the efficacy of DMX-200 in children aged 12 to 17 with focal seg...

Featured News

3DA The US will keep funding onshore manufacturing. Amaero's already winning
right-arrow Created with Sketch.
NEWS West Arunta hits high-grade assays in Luni Drilling
right-arrow Created with Sketch.
NEWS Acquisition of Bullabulling Gold Project by Minerals 260
right-arrow Created with Sketch.
NEWS Harts Range yields strong grades in Niobium, Dysprosium, and Terbium
right-arrow Created with Sketch.
NEWS Gold Mountain Uncovers Significant Lithium Anomalies at Salinas South, Brazil
right-arrow Created with Sketch.
NEWS First Paediatric Patient Recruited for ACTION3 Phase 3 Clinical Trial
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.